2016-14722. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Nonproprietary Naming of Biological Products; Withdrawal
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Withdrawal of notice.
SUMMARY:
This document withdraws a Food and Drug Administration (FDA) notice that published in the Federal Register of June 2, 2016 (81 FR 35367).
DATES:
This notice is withdrawn on June 22, 2016.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Howard Muller, Center for Drug Evaluation and Research (CDER), 10903 New Hampshire Ave., Bldg. 51, Rm. 6234, Silver Spring, MD 20993-0002, 301-796-3474.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
FDA published a notice in the Federal Register of June 2, 2016, informing interested parties that the proposed collection of information entitled “Guidance for Industry on Nonproprietary Naming of Biological Products” had been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 and inviting the public to submit comments on the proposed collection to OMB. FDA is withdrawing the proposed collection of information that published on June 2, 2016, at this time.
Start SignatureDated: June 16, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-14722 Filed 6-21-16; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 06/22/2016
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Withdrawal of notice.
- Document Number:
- 2016-14722
- Dates:
- This notice is withdrawn on June 22, 2016.
- Pages:
- 40704-40704 (1 pages)
- Docket Numbers:
- Docket No. FDA-2013-D-1543
- PDF File:
- 2016-14722.pdf